Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Phenidone Monohydrochloride
1. 92-43-3
2. 1-phenylpyrazolidin-3-one
3. 1-phenyl-3-pyrazolidinone
4. 1-phenyl-3-pyrazolidone
5. Fenidon
6. 3-pyrazolidinone, 1-phenyl-
7. Pyrazolidinone, 1-phenyl-
8. 1-phenyl-3-oxopyrazolidine
9. 2-pyrazolin-3-ol, 1-phenyl-
10. 1-p-3-p
11. 1-phenyl-pyrazolidin-3-one
12. 1-phenylpyrazolid-3-one
13. Chembl7660
14. 1-phenyl-4,5-dihydro-1h-pyrazol-3-ol
15. Mls002639322
16. H0u5612p6k
17. Nsc-30306
18. Ccris 3624
19. Einecs 202-155-1
20. 3-pyrazolidinone,1-phenyl-
21. Unii-h0u5612p6k
22. Phenidone A
23. Mfcd00003094
24. Wln: T5nmvtj Ar
25. N-phenylpyrazolidin-3-one
26. Chemdiv3_006595
27. Timtec1_001225
28. Dsstox_cid_29393
29. Dsstox_rid_83508
30. 1-phenyl Pyrazolidine-3-one
31. Dsstox_gsid_49433
32. Oprea1_428400
33. Schembl235192
34. Schembl9670254
35. Dtxsid1049433
36. Schembl10371905
37. 1-phenyl-3-pyrazolidinone, 97%
38. Hms1491l17
39. Hms1537h15
40. Hms3091p11
41. Hms3886e10
42. Albb-010492
43. Nsc30306
44. Zinc2769764
45. Tox21_202877
46. 1-phenyltetrahydro-3h-pyrazol-3-one
47. Bdbm50009004
48. S5520
49. Stk084358
50. Stk741678
51. Akos000119161
52. Akos003264132
53. (phenidone)1-phenyl-pyrazolidin-3-one
54. 1-phenyl-pyrazolidin-3-one(phenidone)
55. Ccg-207926
56. Cs-w010860
57. Fs-4504
58. Hy-w010144
59. Sdccgmls-0064787.p001
60. Cas-92-43-3
61. Idi1_024505
62. 1-phenyl-3-pyrazolidinone [mi]
63. 1-phenyl-pyrazolidin-3-one (phenidone)
64. Ncgc00174656-01
65. Ncgc00260423-01
66. Smr001548767
67. Db-057302
68. Ft-0608244
69. P0153
70. D78316
71. Sr-01000516084
72. Q-200133
73. Q3297749
74. Sr-01000516084-1
75. F0905-7615
76. 14776-33-1
Molecular Weight | 162.19 g/mol |
---|---|
Molecular Formula | C9H10N2O |
XLogP3 | 0.9 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 1 |
Exact Mass | 162.079312947 g/mol |
Monoisotopic Mass | 162.079312947 g/mol |
Topological Polar Surface Area | 32.3 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 175 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
Lipoxygenase Inhibitors
Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?